SMSPHARMA — SMS Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00- IN₹27.44bn
- IN₹30.04bn
- IN₹7.83bn
- 64
- 15
- 82
- 56
Annual income statement for SMS Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,632 | 5,199 | 5,221 | 7,093 | 7,827 |
| Cost of Revenue | |||||
| Gross Profit | 1,931 | 2,039 | 1,423 | 2,286 | 2,785 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 4,643 | 4,377 | 4,996 | 6,242 | 6,781 |
| Operating Profit | 988 | 822 | 225 | 851 | 1,047 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 911 | 685 | 53.5 | 661 | 923 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 610 | 679 | 38.8 | 492 | 674 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 625 | 622 | -70.6 | 498 | 691 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 625 | 622 | -70.6 | 498 | 691 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.39 | 7.35 | -0.828 | 5.88 | 8.16 |
| Dividends per Share |